Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma
Alessia Villani, Sonia Sofía Ocampo‐Garza, Luca Potestio, et al.
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 1, pp. 21-29
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Immune Checkpoint Inhibitors in Cancer Therapy
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani, et al.
Current Oncology (2022) Vol. 29, Iss. 5, pp. 3044-3060
Open Access | Times Cited: 729
New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
Alessia Villani, Luca Potestio, Gabriella Fabbrocini, et al.
Advances in Therapy (2022) Vol. 39, Iss. 3, pp. 1164-1178
Open Access | Times Cited: 53
Understanding the squamous cell carcinoma immune microenvironment
Vahide Saeidi, Nicole Doudican, John A. Carucci
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Lipid-based nanosystems: the next generation of cancer immune therapy
Ziyun Cheng, Seth‐Frerich Fobian, Elena Gurrieri, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 13
Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities
Stefano Sol, Fabiana Boncimino, Kristina Todorova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7056-7056
Open Access | Times Cited: 8
Management of Advanced Invasive Melanoma: New Strategies
Alessia Villani, Massimiliano Scalvenzi, Giuseppe Micali, et al.
Advances in Therapy (2023) Vol. 40, Iss. 8, pp. 3381-3394
Open Access | Times Cited: 18
Use of Natural Agents and Agrifood Wastes for the Treatment of Skin Photoaging
Melania Parisi, Mariavittoria Verrillo, Maria Antonietta Luciano, et al.
Plants (2023) Vol. 12, Iss. 4, pp. 840-840
Open Access | Times Cited: 16
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review
Luca Potestio, Fabrizio Martora, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 51-57
Open Access | Times Cited: 4
The Past, the Present and the Future of Teledermatology: A Narrative Review
Nello Tommasino, Matteo Megna, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 717-723
Open Access | Times Cited: 4
Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation
Luca Potestio, Massimiliano Scalvenzi, Aimilios Lallas, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1732-1732
Open Access | Times Cited: 4
Editorial: New strategies for the treatment of advanced melanoma and non-melanoma skin cancer
Alessia Villani, Luca Potestio, Aimilios Lallas
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Skin cancer prevention – Recent advances and unmet challenges
Mahsa Mortaja, Shadmehr Demehri
Cancer Letters (2023) Vol. 575, pp. 216406-216406
Open Access | Times Cited: 8
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature
Fabrizio Martora, Teresa Battista, Angelo Ruggiero, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1423-1423
Open Access | Times Cited: 6
Herpes Zoster and COVID-19 Vaccination: A Narrative Review
Luca Potestio, Matteo Megna, Alessia Villani, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 3323-3331
Open Access | Times Cited: 6
An update on the current and emerging pharmacotherapies for basal cell carcinomas
Alessia Villani, Massimiliano Scalvenzi, Giuseppe Micali, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 18, pp. 2143-2151
Closed Access | Times Cited: 4
Management of Locally Advanced Basal Cell Carcinoma with Sonic Hedgehog Pathway Targeted Therapy: A Case Report and Discussion
Neal Ferrin, Darwin Edmond, Ryan Jones, et al.
Case Reports in Dermatology (2024) Vol. 16, Iss. 1, pp. 75-82
Open Access | Times Cited: 1
Comprehensive approaches to preclinical evaluation of monoclonal antibodies and their next-generation derivatives
Santanu Singh, Kajal Kachhawaha, Sumit K. Singh
Biochemical Pharmacology (2024) Vol. 225, pp. 116303-116303
Closed Access | Times Cited: 1
Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral Center
Jonas K. Kurzhals, Gina Klee, Victoria Hagelstein, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10723-10723
Open Access | Times Cited: 7
The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area
Alessia Villani, Gabriella Fabbrocini, Giuseppe Micali, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 9, pp. 2121-2126
Open Access | Times Cited: 3
Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation
Alessandro Villa, Massimiliano Scalvenzi, Giuseppe Micali, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 7, pp. 525-531
Closed Access | Times Cited: 2
Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
Åse Bratland, Eva Muñoz‐Couselo, Laurent Mortier, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 12, pp. 3165-3180
Open Access | Times Cited: 2
Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma
John T. Lear, Linda M. Morris, Dylan B. Ness, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 12, pp. 1211-1220
Open Access | Times Cited: 2
Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
Adam Khorasanchi, Richard Wu, Kari Kendra, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5325-5325
Open Access | Times Cited: 4
Unaddressed Challenges in the Treatment of Cutaneous Melanoma?
Alessia Villani, Luca Potestio, Aimilios Lallas, et al.
Medicina (2024) Vol. 60, Iss. 6, pp. 884-884
Open Access
Autoimmune Skin Diseases and Immune Checkpoint Inhibitors
Davide Fattore, Luca Potestio, Lucia Genco, et al.
Critical Reviews in Immunology (2022) Vol. 42, Iss. 3, pp. 11-22
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top